Prospecive study for treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA) and chemotherapy - AMLCG APL-1994 Study

Trial Profile

Prospecive study for treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA) and chemotherapy - AMLCG APL-1994 Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Sep 2016

At a glance

  • Drugs Tretinoin (Primary) ; Cyclophosphamide; Cytarabine; Cytarabine; Daunorubicin; Mitoxantrone; Tioguanine
  • Indications Acute promyelocytic leukaemia
  • Focus Therapeutic Use
  • Acronyms AMLCG-APL1994
  • Most Recent Events

    • 27 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top